Journal Article Summary
The article investigates the effectiveness and tolerability of a clonidine transdermal patch for treating children with tic disorders (TD). Tic disorders, which include conditions like Tourette's syndrome, are common in children and can significantly affect their quality of life. Traditional treatments, particularly dopamine receptor antagonists, often have side effects that make them difficult for some patients to tolerate. This study aims to explore an alternative treatment option that may be safer and more effective for children who do not respond well to standard medications.
In this study, 41 children aged 6 to 18 with tic disorders participated in a 12-week treatment using clonidine patches after failing to respond adequately to previous dopamine antagonist treatments. The researchers measured tic severity using the Yale Global Tic Severity Scale at the start and at 4, 8, and 12 weeks into the treatment. The results showed that the effectiveness of the clonidine patch improved over time, with 63.41% of participants experiencing significant reductions in tic severity by the end of the study. Adverse effects were minimal, with some patients reporting mild issues like rash and dizziness.
However, the study has limitations, including a small sample size and the lack of a placebo control group, which may affect the reliability of the findings. Patients and caregivers should discuss the potential benefits and risks of using clonidine with a healthcare professional, especially considering that individual responses to treatment can vary. It is important to tailor treatment plans to each child's specific needs and circumstances, particularly if they have a history of poor tolerance to other medications.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Song Pan-Pan, Jiang Li, Li Xiu-juan, Hong Si-Qi, Li Shuang-Zi, Hu Yue. The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study. Frontiers in Neurology 2017. DOI: 10.3389/fneur.2017.00032. PMID: 28280480. PMCID: PMC5322220.
Featured Pill Pals Product
Clonidine 0.2 mg Immediate Release Tablets --- Generic For Catapres --- Aurobindo
Clonidine 0.2 mg Immediate Release Tablets — Generic For Catapres — Aurobindo is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
